# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-26-033429
Filing Date
2026-05-11
Accepted
2026-05-11 16:03:45
Documents
63
Period of Report
2026-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | bcax-20260331.htm iXBRL | 10-Q | 1727155
2 | EX-31.1 | exhibit311q1-26.htm | EX-31.1 | 10473
3 | EX-31.2 | exhibit312q1-26.htm | EX-31.2 | 10399
4 | EX-32.1 | exhibit321q1-26.htm | EX-32.1 | 7600
10 |  | bcax-20260331_g1.jpg | GRAPHIC | 810093
| Complete submission text file | 0001628280-26-033429.txt |  | 8254371

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | bcax-20260331.xsd | EX-101.SCH | 35433
6 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | bcax-20260331_cal.xml | EX-101.CAL | 49499
7 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | bcax-20260331_def.xml | EX-101.DEF | 207389
8 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | bcax-20260331_lab.xml | EX-101.LAB | 511987
9 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | bcax-20260331_pre.xml | EX-101.PRE | 355958
67 | EXTRACTED XBRL INSTANCE DOCUMENT | bcax-20260331_htm.xml | XML | 642707

Mailing Address 116 HUNTINGTON AVENUE SUITE 703 BOSTON MA 02116
Business Address 116 HUNTINGTON AVENUE SUITE 703 BOSTON MA 02116 617-468-4219
Bicara Therapeutics Inc. (Filer) CIK: 0002023658 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42271 | Film No.: 26963064
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)